Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the field of biopharmaceuticals, featuring promising progress across a variety of health-related and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA gives a safer, more trusted substitute for therapeutic use, especially i